Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Azole antifungals reported by Takeda

Oct. 11, 1996

Xoma poised to enter pivotal trials with Neuprex

Oct. 11, 1996

Cubist evaluating new class of antibacterial agents

Oct. 11, 1996

Daiichi discloses quinolone antibacterial agents

Oct. 11, 1996

Yamanouchi awaits marketing approval for Farom

Oct. 11, 1996

New family of marine natural products discovered

Oct. 11, 1996

Fujisawa antibiotic awaiting MHW approval

Oct. 11, 1996

Procter & Gamble focuses on multifunctional antibacterial agents

Oct. 11, 1996

MC-02331, a new cephalosporin with excellent activity against Gram-positive bacteria

Oct. 11, 1996

Metallo-beta-lactamase inhibitors from SKB

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.